Profile
| Metric | Value |
|---|---|
| Full Name | Henry Schein, Inc. |
| Ticker | NASDAQ: HSIC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Country | United States |
| IPO | |
| Indexes | |
| Website | henryschein.com |
| Employees | 25,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $77.21 | |
| Price, 1D Change | -1.61% | |
| Market Cap | $9B | |
| - | ||
| PE Ratio | 24.39 | |
| Beta | 0.56 | |
| Revenue | $13B | |
| Revenue, 1Y Change | +2.71% | |
| EPS | $3.05 | |
| EPS, 1Y Change | -3.34% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 51:40 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $3.05 | |
| EPS Estimate | $4.91 | |
| EPS Est. Change | +60.76% | |
| Revenue | $12.67B | |
| Revenue Estimate | $13.08B | |
| Revenue Est. Change | +3.24% | |
| Current Price | $77.21 | |
| Price Target | - | $78.00 |
| Price Tgt. Change | - | +1.02% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.54 | $3.16 | -30.45% | |
| $4.76 | $3.05 | -35.85% | |
| $4.91 | N/A | +60.76% | |
| $5.29 | N/A | +73.19% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $12.37B | $12.34B | -0.29% | |
| $12.73B | $12.67B | -0.44% | |
| $13.08B | N/A | +3.24% | |
| $13.53B | N/A | +6.73% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +3.29% | |
| Price, 3Y | -5.01% | |
| Market Cap, 1Y | -2.06% | |
| Market Cap, 3Y | -15.15% | |
| Revenue, 1Y | +2.71% | |
| Revenue, 3Y | +2.19% | |
| EPS, 1Y | -3.34% | |
| EPS, 3Y | -30.65% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $77.21 | |
| SMA 200 | $70.17 | |
| SMA 200 vs Price | -9.12% | |
| SMA 50 | $75.53 | |
| SMA 50 vs Price | -2.18% | |
| Beta | 0.56 | |
| ATR | $1.79 | |
| 14-Day RSI | 51.20 | |
| 10-Day Volatility | 29.78% | |
| 1-Year Volatility | 28.58% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $12.67B | |
| EPS | $3.05 | |
| Gross Profit | $4.02B | |
| Gross Margin | 31.69% | |
| Operating Profit | $731.00M | |
| Operating Margin | 5.77% | |
| Net Income | $398.00M | |
| Net Margin | 3.08% | |
| EBITDA | $941.00M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.75 | |
| Current Ratio | 1.42 | |
| Quick Ratio | 0.78 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 3.12 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 24.39 | |
| PS Ratio | 0.70 | |
| PB Ratio | 2.70 | |
| EV/EBITDA | 11.56 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $3.39B | |
| Cash & Equivalents | $122.00M | |
| Total Assets | $10.22B | |
| Current Assets | $3.98B | |
| Total Liabilities | $5.38B | |
| Current Liabilities | $2.80B | |
| Total Debt | $2.87B | |
| Short Term Debt | $781.00M | |
| Accounts Payable | $962.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $11.94B | |
| Operating Expenses | $3.29B | |
| Cost Of Goods Sold | $8.66B | |
| SG&A | $3.03B | |
| D&A | $297.00M | |
| Interest Expense | $0.00 | |
| Income Tax | $128.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $848.00M | |
| CFI | -$430.00M | |
| CFF | -$510.00M | |
| Capex | $187.00M | |
| Free Cash Flow | $661.00M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | ||
| Wells Fargo | → | |
| Morgan Stanley | → | |
| JP Morgan | → | |
| Evercore ISI Group | → | |
| Barrington Research | → | |
| Barrington Research | → | |
| Barrington Research | → | |
| Evercore ISI Group | → | |
| JP Morgan | → |
Analyst sentiment
Institutional ownership
Screeners with HSIC
FAQ
What is the ticker symbol for Henry Schein, Inc.?
The ticker symbol for Henry Schein, Inc. is NASDAQ:HSIC
Does Henry Schein, Inc. pay dividends?
No, Henry Schein, Inc. does not pay dividends
What sector is Henry Schein, Inc. in?
Henry Schein, Inc. is in the Healthcare sector
What industry is Henry Schein, Inc. in?
Henry Schein, Inc. is in the Medical Distribution industry
What country is Henry Schein, Inc. based in?
Henry Schein, Inc. is headquartered in United States
When did Henry Schein, Inc. go public?
Henry Schein, Inc. initial public offering (IPO) was on November 3, 1995
Is Henry Schein, Inc. in the S&P 500?
Yes, Henry Schein, Inc. is included in the S&P 500 index
Is Henry Schein, Inc. in the NASDAQ 100?
No, Henry Schein, Inc. is not included in the NASDAQ 100 index
Is Henry Schein, Inc. in the Dow Jones?
No, Henry Schein, Inc. is not included in the Dow Jones index
When was Henry Schein, Inc. last earnings report?
Henry Schein, Inc.'s most recent earnings report was on November 4, 2025
When does Henry Schein, Inc. report earnings?
The next expected earnings date for Henry Schein, Inc. is February 24, 2026
Data Sources & References
- HSIC Official Website www.henryschein.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1000228/000100022825000066/0001000228-25-000066-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000228/000100022825000014/0001000228-25-000014-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- HSIC Profile on Yahoo Finance finance.yahoo.com/quote/HSIC
- HSIC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hsic